INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia

Published:2024-01 Issue:1 Volume:30 Page:56-70
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Winestone Lena E.^ORCID,Bhojwani Deepa,Ghorashian Sara,Muffly Lori,Leahy Allison Barz,Chao Karen,Steineck Angela^ORCID,Rössig Claudia^ORCID,Lamble Adam,Maude Shannon L.,Myers Regina,Rheingold Susan R.^ORCID

Funder

National Institutes of Health

American Cancer Society

National Cancer Institute

Saint Baldricks Foundation

Pediatric Transplantation and Cellular Therapy Consortium

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference102 articles.

1. Three-year update of tisagenlecleucel in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia in the ELIANA trial;Laetsch;J Clin Oncol,2023

2. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N Engl J Med,2018

3. Successful treatment of chimeric antigen receptor T cell therapy in refractory or relapsed acute leukemia patients with TP53 alterations;Qu;Blood,2019

4. Characteristics and outcomes of patients with Down syndrome-associated acute lymphoblastic leukaemia treated on UKALL 2003;Patrick;Blood,2013

5. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group;Buitenkamp;Blood,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Implementation of Chimeric Antigen Receptor (CAR) T-cell Therapy in Pediatric Patients: Where Did We Come From, Where Are We Now, and Where are We Going?;Clinical Hematology International;2024-03-13

2. Rare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults;Cancers;2024-02-29